• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine Dihydrochloride: A Comprehensive Overview

3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride (CAS No. 1431970-25-0) is a versatile compound with significant potential in the pharmaceutical and chemical industries. This compound, also known as MPPA dihydrochloride, has garnered attention due to its unique chemical structure and biological activity. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological applications, and recent research advancements of this compound.

Chemical Properties

3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride is a white crystalline solid with a molecular formula of C₉H₁₅N₃·2HCl and a molecular weight of 229.69 g/mol. The compound is highly soluble in water and polar organic solvents, making it suitable for various pharmaceutical formulations. Its stability under different conditions, such as temperature and pH, has been extensively studied to ensure its reliability in both laboratory and industrial settings.

Synthesis Methods

The synthesis of 3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride can be achieved through several routes, each with its own advantages and challenges. One common method involves the reaction of 3-chloropropylamine hydrochloride with 4-methylpyrazole in the presence of a base, followed by acidification to form the dihydrochloride salt. Another approach involves the reductive amination of 3-chloropropionaldehyde with 4-methylpyrazole, followed by subsequent steps to form the final product. Recent advancements in green chemistry have led to the development of more environmentally friendly synthesis methods, such as using microwave-assisted reactions and catalysts that minimize waste production.

Biological Applications

3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride has shown promising biological activity in various studies. It is known to act as an agonist for certain receptors, particularly those involved in neurotransmission and cellular signaling pathways. This property makes it a valuable tool in the study of neurological disorders and potential therapeutic applications. For instance, research has demonstrated its potential as a lead compound for developing treatments for conditions such as anxiety, depression, and neurodegenerative diseases.

Clinical Trials and Research Advancements

The clinical potential of 3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride has been explored in several preclinical studies and early-stage clinical trials. These studies have focused on its safety profile, pharmacokinetics, and efficacy in treating specific conditions. Recent findings have highlighted its ability to modulate key signaling pathways involved in neuronal function and synaptic plasticity. Additionally, ongoing research is investigating its potential as a neuroprotective agent and its role in enhancing cognitive function.

Safety Considerations

Safety is a critical aspect of any pharmaceutical compound, and extensive studies have been conducted to evaluate the safety profile of 3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride. Preclinical toxicology studies have shown that it is well-tolerated at therapeutic doses, with minimal adverse effects observed. However, like any drug candidate, it is essential to continue monitoring its safety during clinical trials and post-market surveillance to ensure patient safety.

Conclusion

In conclusion, 3-(1-Methyl-1H-pyrazol-4-yl)propan-1-amine dihydrochloride (CAS No. 1431970-25-0) is a promising compound with a wide range of potential applications in the pharmaceutical industry. Its unique chemical properties, diverse synthesis methods, and significant biological activity make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, it is likely that this compound will play an increasingly important role in advancing medical treatments for various conditions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)